Bicocca Open Archive

Logo unimib boa

Venditti, A., Piciocchi, A., Soddu, S., Frigeni, M., Palmieri, R., Borlenghi, E., et al. (2023). Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial. In 65th ASH Annual Meeting and Exposition - December 9-12, 2023 (pp.1514-1514). AMER SOC HEMATOLOGY [10.1182/blood-2023-178505].

Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial

Cairoli, Roberto;Rambaldi, Alessandro
2023
poster + paper
venetoclax; AML
English
65th ASH Annual Meeting and Exposition - December 9-12, 2023
2023
65th ASH Annual Meeting and Exposition - December 9-12, 2023
BLOOD
2023
142
Supplement 1
1514
1514
none
Venditti, A., Piciocchi, A., Soddu, S., Frigeni, M., Palmieri, R., Borlenghi, E., et al. (2023). Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial. In 65th ASH Annual Meeting and Exposition - December 9-12, 2023 (pp.1514-1514). AMER SOC HEMATOLOGY [10.1182/blood-2023-178505].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/456672
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
Social impact